FibroBiologics (FBLG) filed a registration statement Monday covering the potential resale of up to about 41.3 million of its shares from time to time by a selling stockholder.
The company said it will not receive any proceeds from such sale.
FibroBiologics shares fell 3% in early trading.
Price: 2.29, Change: -0.07, Percent Change: -2.97